Univerdidade Estadual Paulista
Botucatu, São Paulo, 18600-000, Brazil
NCT Number: NCT00511589
T. cruzi infection affects approximately five million people in Brazil. The diagnosis of the chronic phase of infection is performed by indirect serological methods which, nevertheless, leave inconclusive results. One of the direct methods used for T. cruzi identification, blood culture in LIT (liver infusion tryptose) medium, presents low sensitivity in that phase of the disease. A negative result does not eliminate the possibility of infection, but a positive test has high absolute diagnostic value, which enables the indication of antiparasitic treatment. Molecular diagnosis (PCR) in this phase is promising and can be used as a confirmatory test, particularly when individuals present inconclusive results in conventional serological tests, such as ELISA, HAI and IFI. This study aimed at improving blood culture sensitivity in LIT medium by performing PCR in individuals with positive and inconclusive serology for chagasic infection.
Looking for future studies?
Notify Me18 year–60 year
All sexes
Interventional
Not applicable
Botucatu, São Paulo, 18600-000, Brazil
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
UPECLIN HC FM Botucatu Unesp
Other
PCR in Blood Cultures of Individuals With Positive and Inconclusive Serology for Chagas' Disease
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05979207
Anti-Infective Agents, Antimalarials
Brisbane, Queensland, Australia
View Trial DetailsNCT05287893
Infections, Inflammation
Brisbane, Queensland, Australia
View Trial DetailsNCT04310085
Infections, Inflammation
Antwerp, Belgium
View Trial DetailsNCT03399318
Body Temperature Changes, Coma
Blantyre, Malawi
View Trial Details